Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia BLOOD Nand, S., Othus, M., Godwin, J. E., Willman, C. L., Norwood, T. H., Howard, D. S., Coutre, S. E., Erba, H. P., Appelbaum, F. R. 2013; 122 (20): 3432-3439
View details for DOI 10.1182/blood-2013-06-506592
View details for Web of Science ID 000327666500013